← Evidence map

ReviewFrontiers in immunology2022

SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation.

Madison MacDougall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35572514